Showing 381-390 of 1697 results for "".
Multiple Sclerosis Minute: Telemedicine and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-telemedicine-and-multiple-sclerosis/30116/Telemedicine is acceptable to patients and clinicians in the continuum of clinic-to-in-home care and reduces barriers to care.The Fragile X-Associated Tremor/Ataxia Syndrome
https://practicalneurology.com/diseases-diagnoses/movement-disorders/PN0809_08-php/30899/Relatively recently described, FXTAS is a progressive genetic disorder for which there is no cure, but symptomatic therapy is indicated.Headache Medicine: A Crossroad of Otolaryngology, Ophthalmology, and Neurology
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-medicine-a-crossroad-of-otolaryngology-ophthalmology-and-neurology/30611/Numerous symptoms can suggest both ophthalmological and neurological disorders.Dementia Insights
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights/30815/- Epilepsy Care: Can We Succeed with Monotherapy?https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0405CvrStry-pdf/31461/Advancements and Challenges in Antiepileptic Drug MonotherapyIn the realm of epilepsy management, achieving seizure freedom remains the primary goal for neurologists and patients alike. Approximately 60-70% of newly diagnosed epilepsy patients achieve control with a single antiepileptic drug (AED),
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1206Epilepsy-pdf/31237/The Role of Generic Antiepileptic Drugs in Epilepsy ManagementEffective epilepsy treatment aims to achieve seizure freedom without adverse side effects. According to Kwan and Brodie, approximately 64% of patients reach this goal using either monotherapy or a combination of two antiseizure medication
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31344/In February 2006, Practical Neurology highlighted several pivotal developments impacting the neurology field. Notably, Congress approved a budget-cutting bill that President Bush signed into law on February 6th, effectively freezing the Medicare physician reimbursement rates at 2005 levels by haltin
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0805Epilepsy-pdf/31417/Since the 1990s, the Food and Drug Administration has approved numerous new antiepileptic drugs (AEDs) and innovative formulations of existing medications, significantly expanding the therapeutic arsenal for epilepsy management. This proliferation of treatment options holds promise for enhancing the
Genetic Testing in Adults with Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/genetic-testing-in-adults-with-epilepsy/32052/Appropriate treatment of adults with epilepsy requires the practitioner to be familiar with indications for genetic testing, approaches to testing, diagnostic yield, and clinical ramifications of the results.Expert Opinion Cauda Equina Syndrome: A Case Report and Review of the Literature
https://practicalneurology.com/columns/practice-management/expert-opinion-cauda-equina-syndrome-a-case-report-and-review-of-the-literature/30700/